- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GDC-9545/F18 Capsule
Total 96 results
-
Genentech, Inc.CompletedHealthy VolunteersUnited Kingdom
-
Genentech, Inc.CompletedHealthy VolunteersUnited States
-
Hoffmann-La RocheRecruitingEndometrial CancerUnited States, Canada, Italy, Poland
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedBreast CancerUnited States, Spain, Belgium, Australia, United Kingdom
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedHealthy VolunteerUnited States
-
Enzychem Lifesciences CorporationCompleted
-
TaiRx, Inc.CompletedAdvanced CancerTaiwan
-
MedSIRRecruiting
-
Genentech, Inc.Completed
-
Medibiofarma S.L.Completed
-
Yung Shin Pharm. Ind. Co., Ltd.Changhua Christian HospitalCompletedHot Flashes | PMSTaiwan
-
Genentech, Inc.Completed
-
Melcap Systems Ltd.Suspended
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Germany, France, Israel, Italy, United Kingdom
-
Genentech, Inc.WithdrawnHealthy VolunteerUnited Kingdom
-
Hoffmann-La RocheRecruitingEarly Breast CancerUnited States, France, Korea, Republic of, Spain, China, Italy, Taiwan, Sweden, Czechia, Hungary, Japan, Greece, Ukraine, Australia, Brazil, Canada, Mexico, Belgium, Argentina, Chile, Serbia, Colombia, Ireland, Hong Kong, Austria, South Africa and more
-
BioLite, Inc.CompletedA Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)Attention-Deficit Hyperactivity Disorder (ADHD)United States
-
BioLite, Inc.American BriVision CorporationNot yet recruitingMajor Depressive DisorderUnited States
-
AnHeart Therapeutics Inc.RecruitingIDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid TumorCholangiocarcinoma With IDH1 Mutation | Solid Tumors With IDH1 MutationChina
-
Genentech, Inc.Quotient ClinicalCompletedAmyotrophic Lateral SclerosisUnited Kingdom
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
BioLite, Inc.CompletedMajor Depressive DisorderTaiwan, United States
-
TaiRx, Inc.CompletedCarcinoma | Advanced CancerUnited States
-
TaiRx, Inc.CompletedCarcinoma | Advanced CancerTaiwan
-
Enzychem Lifesciences CorporationCompletedChemotherapy-Induced NeutropeniaKorea, Republic of
-
Medibiofarma S.L.Recruiting
-
Enzychem Lifesciences CorporationCompleted
-
BioLite, Inc.ABVC BioPharma, IncSuspendedAttention-Deficit Hyperactivity Disorder (ADHD)United States, Taiwan
-
Enzychem Lifesciences CorporationCompletedFebrile NeutropeniaKorea, Republic of
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
MedSIRRecruitingBreast Cancer | Breast Cancer, Early-OnsetSpain, France
-
Enzychem Lifesciences CorporationCompletedChemotherapy-Induced NeutropeniaKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Swiss Federal Institute of TechnologyCompleted
-
Nucleo De Pesquisa E Desenvolvimento De Medicamentos...University of Campinas, BrazilCompletedBariatric Surgery CandidateBrazil
-
Izmir Katip Celebi UniversityCompleted
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
TakedaCompleted
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, India, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Colombia, Oman, Saudi Arabia, Poland, Egypt, U... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruiting
-
AstraZenecaParexelCompletedChronic Kidney DiseaseGermany
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Tulane UniversityLouisiana Clinical and Translational Science CenterCompleted
-
Fudan UniversityRecruiting